Ten-Gram-Scale Total Synthesis of the Anticancer Drug Candidate E7130 to Supply Clinical Trials
E7130 is a novel drug candidate with an exceedingly complex chemical structure of the halichondrin class, discovered by a total synthesis approach through joint research between the Kishi group at Harvard University and Eisai. Only 18 months after completion of the initial milligram-scale synthesis, ten-gram-scale synthesis of E7130 was achieved, providing the first good manufacturing practice (GMP) batch to supply clinical trials. This paper highlights the challenges in developing ten-gram-scale synthesis from the milligram-scale synthesis.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
|---|---|
| Enthalten in: |
Organic letters - 26(2024), 14 vom: 12. Apr., Seite 2837-2842 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kaburagi, Yosuke [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 15.04.2024 Date Revised 15.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1021/acs.orglett.3c03663 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367433877 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367433877 | ||
| 003 | DE-627 | ||
| 005 | 20240415233125.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240123s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1021/acs.orglett.3c03663 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1376.xml |
| 035 | |a (DE-627)NLM367433877 | ||
| 035 | |a (NLM)38252895 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kaburagi, Yosuke |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Ten-Gram-Scale Total Synthesis of the Anticancer Drug Candidate E7130 to Supply Clinical Trials |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.04.2024 | ||
| 500 | |a Date Revised 15.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a E7130 is a novel drug candidate with an exceedingly complex chemical structure of the halichondrin class, discovered by a total synthesis approach through joint research between the Kishi group at Harvard University and Eisai. Only 18 months after completion of the initial milligram-scale synthesis, ten-gram-scale synthesis of E7130 was achieved, providing the first good manufacturing practice (GMP) batch to supply clinical trials. This paper highlights the challenges in developing ten-gram-scale synthesis from the milligram-scale synthesis | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Antineoplastic Agents |2 NLM | |
| 700 | 1 | |a Kira, Kazunobu |e verfasserin |4 aut | |
| 700 | 1 | |a Yahata, Kenzo |e verfasserin |4 aut | |
| 700 | 1 | |a Iso, Kentaro |e verfasserin |4 aut | |
| 700 | 1 | |a Sato, Yuki |e verfasserin |4 aut | |
| 700 | 1 | |a Matsuura, Fumiyoshi |e verfasserin |4 aut | |
| 700 | 1 | |a Ohashi, Isao |e verfasserin |4 aut | |
| 700 | 1 | |a Matsumoto, Yasunobu |e verfasserin |4 aut | |
| 700 | 1 | |a Isomura, Minetaka |e verfasserin |4 aut | |
| 700 | 1 | |a Sasaki, Takeo |e verfasserin |4 aut | |
| 700 | 1 | |a Fukuyama, Takashi |e verfasserin |4 aut | |
| 700 | 1 | |a Miyashita, Yusuke |e verfasserin |4 aut | |
| 700 | 1 | |a Azuma, Hiroshi |e verfasserin |4 aut | |
| 700 | 1 | |a Iida, Daisuke |e verfasserin |4 aut | |
| 700 | 1 | |a Ishida, Tasuku |e verfasserin |4 aut | |
| 700 | 1 | |a Itano, Wataru |e verfasserin |4 aut | |
| 700 | 1 | |a Matsuda, Masaaki |e verfasserin |4 aut | |
| 700 | 1 | |a Matsukura, Masayuki |e verfasserin |4 aut | |
| 700 | 1 | |a Murai, Norio |e verfasserin |4 aut | |
| 700 | 1 | |a Nagao, Satoshi |e verfasserin |4 aut | |
| 700 | 1 | |a Seki, Masashi |e verfasserin |4 aut | |
| 700 | 1 | |a Yamamoto, Akihiko |e verfasserin |4 aut | |
| 700 | 1 | |a Yamamoto, Yuji |e verfasserin |4 aut | |
| 700 | 1 | |a Yoneda, Naoki |e verfasserin |4 aut | |
| 700 | 1 | |a Watanabe, Yuzo |e verfasserin |4 aut | |
| 700 | 1 | |a Kamada, Atsushi |e verfasserin |4 aut | |
| 700 | 1 | |a Kayano, Akio |e verfasserin |4 aut | |
| 700 | 1 | |a Tagami, Katsuya |e verfasserin |4 aut | |
| 700 | 1 | |a Asano, Osamu |e verfasserin |4 aut | |
| 700 | 1 | |a Owa, Takashi |e verfasserin |4 aut | |
| 700 | 1 | |a Kishi, Yoshito |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Organic letters |d 1999 |g 26(2024), 14 vom: 12. Apr., Seite 2837-2842 |w (DE-627)NLM106817639 |x 1523-7052 |7 nnns |
| 773 | 1 | 8 | |g volume:26 |g year:2024 |g number:14 |g day:12 |g month:04 |g pages:2837-2842 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1021/acs.orglett.3c03663 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 26 |j 2024 |e 14 |b 12 |c 04 |h 2837-2842 | ||